Aim: To report the Italian data deriving from the ESC-EORP Atrial Fibrillation Ablation Long-Term (AFA LT) registry.Methods and results: Ten Italian centers enrolled up to 50 consecutive patients undergoing AF ablation. Of 318 patients included 5 (1.6%) did not undergo catheter ablation, 1 had ablation partially done and 62 were lost at 1-year follow-up. Women were less represented (23.6%) and the median age was 60.0 years. 195 patients (62.3%) suffered paroxysmal AF, whereas only 9 (2.9%) had long-standing persistent AF. Most Italian patients (92.3%) were symptomatic but suffering less symptomatic events than patients enrolled in other countries (median of 2 events in the month preceding the ablation vs. 3, respectively; p<0.0001). The main finding of the study is that the success rate at 1-year, with and without antiarrhythmic drugs, was 76.4%, consistent with other participating countries (73.4%). This result was obtained however with a significantly lower prevalence of 1-year adverse events (7.3% vs. 16.6%, p<0.0001). Procedure duration and fluoroscopy total time resulted shorter in Italy (145 vs. 160, p=0.0005, and 16.9 vs. 20.0 minutes, p=0.0018, respectively); however, radiation dose per body surface area was greater (37.5 vs. 26.0 mGy/cm2, p=0.0022).
Conclusion:The demographic characteristics of patients undergoing AF ablation are similar to those reported in other countries. The success rate in Italy is consistent with other countries, whereas the complications rate is lower.